1-203683210-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_001684.5(ATP2B4):​c.5C>T​(p.Thr2Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000473 in 1,613,070 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.00051 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 5 hom. )

Consequence

ATP2B4
NM_001684.5 missense

Scores

1
8
8

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.17

Publications

4 publications found
Variant links:
Genes affected
ATP2B4 (HGNC:817): (ATPase plasma membrane Ca2+ transporting 4) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 4. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010277808).
BP6
Variant 1-203683210-C-T is Benign according to our data. Variant chr1-203683210-C-T is described in ClinVar as [Benign]. Clinvar id is 1626186.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 77 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2B4NM_001684.5 linkc.5C>T p.Thr2Met missense_variant Exon 2 of 21 ENST00000357681.10 NP_001675.3 P23634-6A0A024R968
ATP2B4NM_001001396.3 linkc.5C>T p.Thr2Met missense_variant Exon 2 of 22 NP_001001396.1 P23634-2
ATP2B4NM_001365783.2 linkc.5C>T p.Thr2Met missense_variant Exon 2 of 21 NP_001352712.1
ATP2B4NM_001365784.2 linkc.5C>T p.Thr2Met missense_variant Exon 2 of 21 NP_001352713.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2B4ENST00000357681.10 linkc.5C>T p.Thr2Met missense_variant Exon 2 of 21 1 NM_001684.5 ENSP00000350310.5 P23634-6
ATP2B4ENST00000341360.7 linkc.5C>T p.Thr2Met missense_variant Exon 2 of 22 1 ENSP00000340930.2 P23634-2
ATP2B4ENST00000705901.1 linkc.5C>T p.Thr2Met missense_variant Exon 2 of 21 ENSP00000516177.1 P23634-3

Frequencies

GnomAD3 genomes
AF:
0.000506
AC:
77
AN:
152166
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000971
AC:
243
AN:
250326
AF XY:
0.000850
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00140
Gnomad ASJ exome
AF:
0.0166
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000133
Gnomad OTH exome
AF:
0.00197
GnomAD4 exome
AF:
0.000470
AC:
686
AN:
1460786
Hom.:
5
Cov.:
29
AF XY:
0.000454
AC XY:
330
AN XY:
726608
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33468
American (AMR)
AF:
0.00134
AC:
60
AN:
44648
Ashkenazi Jewish (ASJ)
AF:
0.0173
AC:
450
AN:
26074
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86134
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53386
Middle Eastern (MID)
AF:
0.000352
AC:
2
AN:
5682
European-Non Finnish (NFE)
AF:
0.0000801
AC:
89
AN:
1111376
Other (OTH)
AF:
0.00138
AC:
83
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
34
67
101
134
168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000506
AC:
77
AN:
152284
Hom.:
1
Cov.:
32
AF XY:
0.000484
AC XY:
36
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41558
American (AMR)
AF:
0.000915
AC:
14
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
52
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68026
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00106
Hom.:
5
Bravo
AF:
0.000612
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000684
AC:
83
EpiCase
AF:
0.000491
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

ATP2B4-related disorder Benign:1
Jul 15, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Apr 25, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
-0.050
CADD
Uncertain
24
DANN
Pathogenic
1.0
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.70
T;T;.
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.010
T;T;T
MetaSVM
Uncertain
0.73
D
MutationAssessor
Benign
1.5
L;L;L
PhyloP100
1.2
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.95
N;N;N
REVEL
Benign
0.27
Sift
Uncertain
0.0010
D;D;D
Sift4G
Uncertain
0.0050
D;D;D
Polyphen
0.99
D;.;.
Vest4
0.14
MVP
0.53
MPC
1.3
ClinPred
0.064
T
GERP RS
5.9
PromoterAI
-0.039
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
gMVP
0.45
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140289832; hg19: chr1-203652338; API